Griffen Mustion
Washington University in St. Louis1 paperORCID 0009-0005-5505-5775OpenAlex
Papers
Nature GeneticsHumans
Germline HRD limits therapy-driven clonal hematopoiesis
Serial blood samples revealed carboplatin and PARP inhibitors expand DNA damage response clones, though germline homologous recombination deficiency…Serial blood samples revealed carboplatin and PARP inhibitors expand DNA damage response clones, though germline homologous recombination deficiency reduces this growth.